- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ATAI Life Sciences BV (ATAI)
Assess today's live ATAI Life Sciences BV (ATAI) share price, performance and insights using our live NASDAQ: ATAI stock exchange data.
Analyse the historical data and ATAI Life Sciences BV share price performance charts on this page. Our technical summary section provides analysis on ATAI Life Sciences BV share price buy/sell indicators using real-time data (or discuss the ATAI Life Sciences BV (ATAI) stock price today with other investors in the ATAI Life Sciences BV NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ATAI share price (ISIN: NL0015000DX5) to enhance your trading decisions with our free investment tools and resources.
What Is the ATAI Life Sciences BV Share Price Today?
The ATAI Life Sciences BV share price today is 4.330.
What Is the Stock Symbol for ATAI Life Sciences BV
The stock symbol (or 'ticker') for ATAI Life Sciences BV is "ATAI."
What Stock Exchange Does ATAI Life Sciences BV Trade On?
ATAI Life Sciences BV is listed and trades on the NASDAQ stock exchange.
Is ATAI Life Sciences BV a Good Stock to Buy?
Determining whether ATAI Life Sciences BV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and ATAI Life Sciences BV share price performance charts on this page. Our technical summary section provides analysis on ATAI Life Sciences BV share price buy/sell indicators using real-time data (or discuss the ATAI Life Sciences BV (ATAI) stock price today with other investors in the ATAI Life Sciences BV NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ATAI share price (ISIN: NL0015000DX5) to enhance your trading decisions with our free investment tools and resources.
What Is the ATAI Life Sciences BV Share Price Today?
The ATAI Life Sciences BV share price today is 4.330.
What Is the Stock Symbol for ATAI Life Sciences BV
The stock symbol (or 'ticker') for ATAI Life Sciences BV is "ATAI."
What Stock Exchange Does ATAI Life Sciences BV Trade On?
ATAI Life Sciences BV is listed and trades on the NASDAQ stock exchange.
Is ATAI Life Sciences BV a Good Stock to Buy?
Determining whether ATAI Life Sciences BV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.250
4.720
52 wk Range
1.150
6.750
ATAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.2504.720
52 wk Range
1.1506.750
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATAI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
12.000
Upside
+177.14%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
ATAI Life Sciences BV Company Profile
Atai Beckley N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic in Phase 2a trial for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists in preclinical studies for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. The company was formerly known as ATAI Life Sciences N.V. and changed its name to Atai Beckley N.V. in November 2025. Atai Beckley N.V. was founded in 2018 and is headquartered in Amstelveen, The Netherlands.
Compare ATAI to Peers and Sector
Metrics to compare | ATAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.2x | −4.5x | −0.6x | |
PEG Ratio | 3.14 | −1.19 | 0.00 | |
Price/Book | 9.8x | 2.7x | 2.6x | |
Price / LTM Sales | 521.1x | 2.7x | 3.2x | |
Upside (Analyst Target) | 177.1% | 19.0% | 41.8% | |
Fair Value Upside | Unlock | −8.2% | 5.1% | Unlock |
Analyst Ratings
11 Buy
0 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12.000
(+177.14% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.28 / -0.11
Revenue / Forecast
750.00K / --
People Also Watch
FAQ
What Is the ATAI Life Sciences BV (ATAI) Share Price Today?
The live ATAI Life Sciences BV share price today is 4.330
What Stock Exchange Does ATAI Life Sciences BV (ATAI) Trade On?
ATAI Life Sciences BV is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for ATAI Life Sciences BV?
The stock symbol (also called a 'ticker') for ATAI Life Sciences BV is "ATAI."
What Is the Current ATAI Life Sciences BV Market Cap?
As of today, ATAI Life Sciences BV market capitalisation is 1.57B.
What Is ATAI Life Sciences BV's (ATAI) Earnings Per Share (TTM)?
The ATAI Life Sciences BV EPS is currently -0.82 (Trailing Twelve Months).
When Is the Next ATAI Life Sciences BV Earnings Date?
ATAI Life Sciences BV's next earnings report will be released on 26 Mar 2026.
Is ATAI a Buy or Sell From a Technical Analyst Perspective?
Based on today's ATAI Life Sciences BV moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has ATAI Life Sciences BV Stock Split?
ATAI Life Sciences BV has split 0 times. (See the ATAI stock split history page for full effective split date and price information.)
How Many Employees Does ATAI Life Sciences BV Have?
ATAI Life Sciences BV has 54 employees.
What is the current trading status of ATAI Life Sciences BV (ATAI)?
As of 24 Dec 2025, ATAI Life Sciences BV (ATAI) is trading at a price of 4.330, with a previous close of 4.300. The stock has fluctuated within a day range of 4.250 to 4.720, while its 52-week range spans from 1.150 to 6.750.
What Is ATAI Life Sciences BV (ATAI) Price Target According to Analysts?
The average 12-month price target for ATAI Life Sciences BV is USD12, with a high estimate of USD16 and a low estimate of USD7. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +177.14% Upside potential.
What Is the ATAI Premarket Price?
ATAI's last pre-market stock price is 4.430. The pre-market share volume is 137,210.000, and the stock has decreased by 0.130, or 3.020%.
What Is the ATAI After Hours Price?
ATAI's last after hours stock price is 4.300, the stock has decreased by -0.030, or -0.690%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.